Interactions between Δ9-tetrahydrocannabinol and kappa opioids in mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 268, Issue 3, 1994, Pages 1381-1387

  Smith, P B ^a   Welch, S P ^a   Martin, B R ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; ENADOLINE; KAPPA OPIATE RECEPTOR; NORBINALTORPHIMINE; TETRAHYDROCANNABINOL;

ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; CATALEPSY; DOSE RESPONSE; DRUG EFFECT; DRUG RECEPTOR BINDING; HYPOTHERMIA; MALE; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; TAIL FLICK TEST;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANALGESICS; ANIMAL; BENZOFURANS; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALINS; MALE; MICE; MICE, INBRED ICR; NALTREXONE; PYRROLIDINES; RECEPTORS, OPIOID, KAPPA; TETRAHYDROCANNABINOL;

EID: 0028261433     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)